RUBY
Rubius Therapeutics Inc
Price:  
0.08 
USD
Volume:  
18,983,900.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RUBY Relative Valuation

-102435.6%
Upside

As of 2025-07-08, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (84.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -102435.6%.

The range of the Relative Valuation is (71.25) - (83.93) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.1x - 29.0x 26.6x
Forward P/E multiples 24.6x - 40.7x 32.1x
Fair Price (71.25) - (83.93) (84.94)
Upside -85943.4% - -101215.3% -102435.6%
0.08 USD
Stock Price
(84.94) USD
Fair Price

RUBY Relative Valuation - Historical P/E Data

Date P/E